Indumathi Mariappan

Bellary Road
Bengaluru, KA 560065, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Journal: Stem cell reports

Published: November 26, 2025

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Journal: Stem cell reports

Published: November 26, 2025

Creating a roadmap to fast-track human-centric non-animal methodologies via innovative funding mechanisms and strategic partnerships.

Creating a roadmap to fast-track human-centric non-animal methodologies via innovative funding mechanisms and strategic partnerships.

Journal: ALTEX

Published: September 01, 2025

Host-membrane lipid composition controls Cryptococcus neoformans cellular targets.

Host-membrane lipid composition controls Cryptococcus neoformans cellular targets.

Journal: Frontiers in immunology

Published: August 16, 2025

Loss of retinal stem cell reserve and lipofuscin accumulation accelerates cone-rod degeneration and replicates Stargardt disease in abca4b null zebrafish.

Loss of retinal stem cell reserve and lipofuscin accumulation accelerates cone-rod degeneration and replicates Stargardt disease in abca4b null zebrafish.

Journal: Scientific reports

Published: August 11, 2025

Generation and validation of a Leber Congenital Amaurosis, Type 12 patient-specific iPSC line (LVPEIi006-B) with a splice-site mutation in RD3 and an isogenic mutation-corrected iPSC line (LVPEIi006-B-1).

Generation and validation of a Leber Congenital Amaurosis, Type 12 patient-specific iPSC line (LVPEIi006-B) with a splice-site mutation in RD3 and an isogenic mutation-corrected iPSC line (LVPEIi006-B-1).

Journal: Stem cell research

Published: March 01, 2025

PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics.

PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics.

Journal: Nature communications

Published: April 03, 2024

Generation and characterization of a Stargardt's disease-specific induced pluripotent stem cell line (LVPEIi008-A) with a homozygous nonsense mutation in exon 44 of ABCA4.

Generation and characterization of a Stargardt's disease-specific induced pluripotent stem cell line (LVPEIi008-A) with a homozygous nonsense mutation in exon 44 of ABCA4.

Journal: Stem cell research

Published: March 25, 2024

Generation of two induced pluripotent stem cell lines (LVPEIi007-B, LVPEIi008-B) from patients harboring homozygous mutation in ABCA4 (c.6088C>T) using non-integrative Sendai virus-based approach.

Generation of two induced pluripotent stem cell lines (LVPEIi007-B, LVPEIi008-B) from patients harboring homozygous mutation in ABCA4 (c.6088C>T) using non-integrative Sendai virus-based approach.

Journal: Stem cell research

Published: February 01, 2024

Generation of Leber congenital amaurosis, type 12 patient-specific induced pluripotent stem cell line (LVPEIi006-A), harboring a homozygous mutation in RD3.

Generation of Leber congenital amaurosis, type 12 patient-specific induced pluripotent stem cell line (LVPEIi006-A), harboring a homozygous mutation in RD3.

Journal: Stem cell research

Published: January 29, 2024

Generation of two induced pluripotent stem cell lines (LVPEIi004-A and LVPEIi005-A) from probands with Leber Congenital Amaurosis 2 (LCA2) and harboring mutations in RPE65.

Generation of two induced pluripotent stem cell lines (LVPEIi004-A and LVPEIi005-A) from probands with Leber Congenital Amaurosis 2 (LCA2) and harboring mutations in RPE65.

Journal: Stem cell research

Published: January 29, 2024

Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.

Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.

Journal: Stem cell research

Published: January 06, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026